Arteris (NASDAQ:AIP) Rating Increased to Buy at Jefferies Financial Group

Jefferies Financial Group upgraded shares of Arteris (NASDAQ:AIP) from a hold rating to a buy rating in a research note published on Friday morning, Marketbeat.com reports. The brokerage currently has $50.00 price objective on the stock.

Several other research analysts have also recently issued reports on the stock. Rosenblatt Securities restated a “buy” rating and issued a $38.00 target price on shares of Arteris in a report on Friday. Roth Capital assumed coverage on shares of Arteris in a research report on Tuesday. They issued a “buy” rating and a $40.00 price target for the company. Oppenheimer initiated coverage on shares of Arteris in a research note on Thursday, July 16th. They issued an “outperform” rating and a $40.00 price objective for the company. TD Cowen raised their price objective on Arteris from $22.00 to $40.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Finally, Weiss Ratings cut Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Five analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $41.00.

Arteris Price Performance

Shares of NASDAQ AIP opened at $29.78 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.73 and a current ratio of 0.73. Arteris has a fifty-two week low of $8.42 and a fifty-two week high of $50.26. The firm has a market capitalization of $1.37 billion, a PE ratio of -34.23 and a beta of 1.96. The stock’s 50-day simple moving average is $35.94 and its 200-day simple moving average is $26.19.

Arteris (NASDAQ:AIP) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). The company had revenue of $24.13 million during the quarter, compared to analysts’ expectations of $23.48 million. As a group, equities research analysts forecast that Arteris will post -0.58 EPS for the current fiscal year.

Insider Buying and Selling at Arteris

In other Arteris news, VP Paul L. Alpern sold 4,000 shares of the firm’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $30.04, for a total transaction of $120,160.00. Following the transaction, the vice president directly owned 70,733 shares of the company’s stock, valued at approximately $2,124,819.32. This trade represents a 5.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Saiyed Atiq Raza sold 70,000 shares of Arteris stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $30.01, for a total transaction of $2,100,700.00. The SEC filing for this sale provides additional information. Insiders have sold 1,498,949 shares of company stock worth $52,200,293 in the last 90 days. Company insiders own 23.30% of the company’s stock.

Hedge Funds Weigh In On Arteris

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. purchased a new stake in Arteris during the 2nd quarter valued at approximately $160,129,000. Westerly Capital Management LLC grew its stake in shares of Arteris by 109.6% in the 3rd quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock valued at $14,392,000 after purchasing an additional 745,000 shares during the last quarter. Nuveen LLC increased its holdings in shares of Arteris by 872.3% in the fourth quarter. Nuveen LLC now owns 737,281 shares of the company’s stock valued at $11,428,000 after purchasing an additional 661,454 shares during the period. Goldman Sachs Group Inc. increased its holdings in shares of Arteris by 144.7% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company’s stock valued at $15,696,000 after purchasing an additional 598,840 shares during the period. Finally, Granahan Investment Management LLC raised its stake in shares of Arteris by 201.0% during the first quarter. Granahan Investment Management LLC now owns 713,077 shares of the company’s stock worth $11,723,000 after purchasing an additional 476,181 shares during the last quarter. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Arteris News Roundup

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Jefferies upgraded Arteris from Hold to Buy and assigned a $50 price target, indicating substantial potential upside. Jefferies upgrade
• Positive Sentiment: Rosenblatt Securities reaffirmed its Buy rating and raised or maintained a $38 price target, while Roth Capital also initiated coverage with a Buy rating and a $40 target. The endorsements strengthen the bullish analyst backdrop for AIP. Rosenblatt rating Roth Capital rating
• Positive Sentiment: Arteris projected third-quarter revenue of $24 million to $25 million and updated full-year 2026 revenue guidance to $95 million to $98 million. Both ranges exceed consensus estimates of approximately $23.5 million and $94.2 million, respectively. Arteris results and guidance
• Neutral Sentiment: The company appointed Saurabh Sinha as chief financial officer and chief accounting officer, effective September 8, 2026. The leadership change may improve financial oversight, but investors may initially monitor the transition. CFO appointment
• Negative Sentiment: Second-quarter adjusted results showed a loss of $0.10 per share, worse than the expected loss of roughly $0.04-$0.05. Revenue of $24.13 million exceeded estimates, but the larger-than-expected loss likely drove selling pressure. Arteris second-quarter results
• Negative Sentiment: Recent filings disclosed sales by CEO K. Charles Janac, director Saiyed Atiq Raza, major shareholder Bayview Legacy and Vice President Paul Alpern. The concentration of insider selling may weigh on sentiment, although insiders retain significant positions.

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.